[{"Assets_0_Q3_USD":43697000.0,"CommonStockSharesOutstanding_0_Q3_shares":18035025.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-19356000.0,"NetIncomeLoss_1_Q3_USD":-9018000.0,"NetIncomeLoss_3_Q3_USD":-24693000.0,"StockholdersEquity_0_Q3_USD":34420000.0,"Ticker":"BTAI","CIK":"1720893","name":"BIOXCEL THERAPEUTICS, INC.","OfficialName":"BioXcel Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"417746551.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191114"}]